Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Mai 2025 05:31 ET | Quelle: Research and Markets

Assessment of the Hepatitis B Pipeline Landscape 2025: Explore Key Player Activities, Collaborations, and Licensing

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis B - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive insights of...
28. Februar 2025 06:34 ET | Quelle: Research and Markets

Hepatitis B Therapeutics Competitive Landscape Report: 184 Molecules in the Pipeline - 1 Asset in Pre-registration Stage, 1 Asset in Phase III Development, and 36 Assets in Phase II Development

Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis B Therapeutics: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven...
18. April 2024 11:44 ET | Quelle: Research and Markets

Hepatitis B Drug Pipeline Research Report 2024

Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive insights of...
23. Februar 2021 08:28 ET | Quelle: Research and Markets

Global $35.63 Billion Hepatitis B Virus (HBV) Market to 2030: Focus on European Union, United States & Japan

Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatitis B Virus (HBV) Market: 10 Year Demand Forecast & Impact of COVID-19 (2021-2030)" report has been added to ResearchAndMarkets.com's...